Quest Diagnostics (DGX) Reports In-Line Q2 EPS, Slight Revenue Miss; Narrows FY18 EPS Outlook, Lowers FY18 Revenue Mid-Point Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. CHWY
4. USO
5. NAVN
6. SPCX
7. HUMA
8. cASY
9. CME
10. TSLA

Go back to Quest Diagnostics (DGX) Reports In-Line Q2 EPS, Slight Revenue Miss; Narrows FY18 EPS Outlook, Lowers FY18 Revenue Mid-Point Guidance
Quest Diagnostics (NYSE: DGX) Delayed: 206.15 +2.37 (1.16%)
Previous Close $203.78    52 Week High $86.85 
Open $204.07    52 Week Low $59.66 
Day High $207.50    P/E 38.82 
Day Low $204.07    EPS $5.31 
Volume 153,577